Guanethidine


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001919 Bradycardia PMID:541046
MESH:D002544 Cerebral Infarction PMID:62901
MESH:D003866 Depressive Disorder PMID:4431808
MESH:D003967 Diarrhea PMID:6850722
MESH:D004417 Dyspnea PMID:5676415
MESH:D005221 Fatigue PMID:5676415
MESH:D006261 Headache PMID:5676415
MESH:D006323 Heart Arrest PMID:5552112
MESH:D006973 Hypertension PMID:493191; PMID:677215
MESH:D007022 Hypotension PMID:10549407; PMID:2862255; PMID:341940; PMID:3688391; PMID:981091
MESH:D007024 Hypotension, Orthostatic PMID:127594; PMID:1665057; PMID:4607314; PMID:4726158; PMID:62901; PMID:7070101
MESH:D007172 Erectile Dysfunction PMID:4607314
MESH:D009203 Myocardial Infarction PMID:62901
MESH:D009410 Nerve Degeneration PMID:438995; PMID:4628152
MESH:D013035 Spasm PMID:623942
MESH:D017180 Tachycardia, Ventricular PMID:6057135
MESH:D018908 Muscle Weakness PMID:4607314
MESH:D054138 Sinus Arrest, Cardiac PMID:541046
MESH:D054537 Atrioventricular Block PMID:5638475

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.